Concentra Group Holdings Parent, Inc. (CON) Stock Analysis
Healthcare · Medical Care Facilities · NYSE
Concentra Group Holdings Parent, Inc. (CON) posted $2.16B in revenue for fiscal 2025 (up 13.9% year over year), at a 7.7% net margin, and has compounded revenue about 7.9%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. has grown revenue from $1.72B to $2.16B over the last 4 fiscal years, compounding about 7.9% a year. The most recent year was up 13.9%, so growth is actually accelerating.
Net margin sits at 7.7%, down 1.1 points year over year.
At today's valuation the market is pricing in roughly 5.6% annual free-cash-flow growth.
Synthesised from Concentra Group Holdings Parent, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
Concentra Group Holdings Parent, Inc. revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $1.72B | $1.84B | $1.90B | $2.16B |
| Gross profit | — | — | — | — |
| Net income | $166.73M | $179.95M | $166.54M | $166.41M |
| Net margin | 9.7% | 9.8% | 8.8% | 7.7% |
Source: Concentra Group Holdings Parent, Inc. SEC filings (10-K).
Concentra Group Holdings Parent, Inc.: no obvious red flags in the filings
Our deterministic scan of the filed statements — receivables vs sales, earnings vs cash, dilution, leverage and margins — didn't flag anything. Ask about the risks →
What growth is priced into CON stock?
At today's market cap of $3.37B, Concentra Group Holdings Parent, Inc. is priced for free-cash-flow growth of about 5.6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $197.06M from the FY ending 2025-12-31). This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 4 years of Concentra Group Holdings Parent, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track CON in your portfolio →
Concentra Group Holdings Parent, Inc. financial history by metric
Compare Concentra Group Holdings Parent, Inc. with peers
About Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas.
Concentra Group Holdings Parent, Inc. — frequently asked questions
What is Concentra Group Holdings Parent, Inc.'s revenue?
Concentra Group Holdings Parent, Inc. (CON) reported revenue of $2.16B for fiscal year 2025, up 13.9% from the prior year, according to its SEC filings.
Is Concentra Group Holdings Parent, Inc. profitable?
Yes. CON earned net income of $166.41M in fiscal 2025, a net margin of 7.7%.
What is CON's P/E ratio?
Concentra Group Holdings Parent, Inc. trades at a price-to-earnings ratio of about 19.0 based on the latest data in our nightly-refreshed cache.
How fast is Concentra Group Holdings Parent, Inc. growing?
CON's revenue grew at roughly 7.9% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Concentra Group Holdings Parent, Inc. have?
As of fiscal year 2025, CON carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Concentra Group Holdings Parent, Inc.'s market cap?
Concentra Group Holdings Parent, Inc. (CON) has a market capitalization of about $3.37B, based on the latest data in our nightly-refreshed cache.
When does Concentra Group Holdings Parent, Inc.'s fiscal year end?
CON's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into CON stock?
At today's market cap of $3.37B, Concentra Group Holdings Parent, Inc. is priced for free-cash-flow growth of about 5.6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $197.06M from the FY ending 2025-12-31).
Where does this data come from?
All figures are computed from Concentra Group Holdings Parent, Inc.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.